|
Business and Presentation (Details Textual) (USD $)
|
1 Months Ended |
12 Months Ended |
1 Months Ended |
3 Months Ended |
|
|
Jan. 31, 2013
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Jun. 25, 2014
|
Mar. 31, 2014
|
Dec. 31, 2012
|
| Concentration Risk, Percentage |
|
5.00% |
|
|
|
|
| Allowance for Doubtful Accounts Receivable |
|
$ 32,469 |
$ 16,497 |
|
|
$ 42,709 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount |
|
200,989,054 |
61,134,957 |
|
|
|
| Repayments of Notes Payable |
|
6,201,143 |
1,020,000 |
|
|
|
| Debt Conversion, Converted Instrument, Amount |
|
3,067,423 |
523,927 |
|
|
|
| Cash |
|
15,946,425 |
3,286,713 |
|
|
2,615,805 |
| Deferred Licensing Revenue |
|
1,442,000 |
|
|
|
|
| Licenses Revenue |
|
402,264 |
167,657 |
|
|
|
| Medical Device Excise Tax Percentage |
2.30% |
|
|
|
|
|
| Minimum Cash Balance |
|
5,000,000 |
|
|
|
|
| Restructuring Reserve |
|
413,000 |
|
|
|
|
| Product Warranty Accrual, Warranties Issued |
|
600,000 |
|
|
|
|
| Inventory Valuation Reserves |
|
90,000 |
0 |
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
3 years |
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
5 years |
|
|
|
|
| Furniture Lab And Manufacturing Equipment [Member] | Minimum [Member] |
|
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
7 years |
|
|
|
|
| Furniture Lab And Manufacturing Equipment [Member] | Maximum [Member] |
|
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
10 years |
|
|
|
|
| Centrifuges [Member] | Minimum [Member] |
|
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
3 years |
|
|
|
|
| Centrifuges [Member] | Maximum [Member] |
|
|
|
|
|
|
| Property, Plant and Equipment, Useful Life |
|
6 years |
|
|
|
|
| Safe Harbor Plan [Member] |
|
|
|
|
|
|
| Defined Contribution Plan, Employer Discretionary Contribution Amount |
|
175,000 |
164,000 |
|
|
|
| Convertible Debt Facility [Member] |
|
|
|
|
|
|
| Convertible Debt |
|
|
|
|
35,000,000 |
|
| Proceeds from Convertible Debt |
|
|
|
26,000,000 |
9,000,000 |
|
| Proceeds From Issuance Of Common Stock And Warrants |
|
|
|
|
2,000,000 |
|
| Repayments of Notes Payable |
|
|
|
|
5,900,000 |
|
| Repayments of Convertible Debt |
|
|
|
|
300,000 |
|
| Debt Conversion, Converted Instrument, Amount |
|
|
|
|
3,100,000 |
|
| Federal Deposit Insurance Corporation [Member] |
|
|
|
|
|
|
| Cash, Uninsured Amount |
|
15,486,000 |
2,667,000 |
|
|
|
| Arthrex [Member] | Accounts Receivable [Member] |
|
|
|
|
|
|
| Concentration Risk, Percentage |
|
64.00% |
|
|
|
|
| Arthrex [Member] | Sales Revenue, Net [Member] |
|
|
|
|
|
|
| Concentration Risk, Percentage |
|
91.00% |
47.00% |
|
|
|
| Aldagen Inc [Member] |
|
|
|
|
|
|
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |
|
422,000 |
|
|
|
|
| Angel [Member] |
|
|
|
|
|
|
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net |
|
$ 707,000 |
|
|
|
|
| Angel [Member] | Arthrex [Member] |
|
|
|
|
|
|
| Concentration Risk, Percentage |
|
100.00% |
|
|
|
|
| Non United States [Member] |
|
|
|
|
|
|
| Percentage Of Product Sales |
|
27.00% |
9.00% |
|
|
|